Tag: and

MARLBOROUGH, Mass., Jan. 07, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (NASDAQ: AKYA), The Spatial Biology Company®, today announced that ...

Collaboration leverages Tenacia’s expertise in central nervous system drug development and commercialization and will address a significant unmet patient need ...

LONDON, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient ...

SEATTLE, Oct. 13, 2023 (GLOBE NEWSWIRE) -- Today, the Snoqualmie Casino announced the renewal of its longstanding partnership with the ...

In 2H 2024, expect to provide Phase 2a topline proof-of-concept data from our wholly-owned lead program SPR720 in NTM-PD patients ...

- EU Clinical Trials authorized for Phase 1b/2a SPOTLIGHT and BEACON studies of briquilimab in CIndU and CSU, respectively - ...

Cash runway anticipated to be extended from Q2 2025 to Q4 2025Data from multiple Phase 1 and 2 clinical trials ...

TARRYTOWN, N.Y., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its ...

George Town, Cayman Islands, Jan. 05, 2024 (GLOBE NEWSWIRE) -- We are a club that is constantly creating art, and ...

George Town, Cayman Islands, Jan. 05, 2024 (GLOBE NEWSWIRE) -- The value we currently see in NFT basically stems from ...